new semaglutide injection Why weight-loss drugs became more popular than ever this year Novo Nordisk Drops Hims &

Non-Infringement and Claim Construction The Delaware courts decision rested on claim construction, interpreting the #003 patents limitation of administering semaglutide without another therapeutic agent. During prosecution, Novo Nordisk narrowed the claim to a maximum dose of 1.6 mg to secure approval, limiting its scope (Casetext, March 25, 2024)

The need-to-know this morning BrainStorm Cell Therapeutics withdrew its FDA application for NurOwn, the companys investigational treatment for ALS, and acknowledged it will need to conduct another pivotal trial

[DOI] [PubMed] [Google Scholar] 164.Amin K., Telesford I., Singh R., Cox C

Clinical oversight and service model Both Cora Health and Ro rely primarily on asynchronous telehealth evaluations for GLP-1 prescribing

Yes, Midi Health is a licensed telehealth platform connecting patients with physicians for GLP-1 prescriptions